FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+27.83%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$286M
AUM Growth
+$286M
(+16%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-6.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
2
Increased
2
Reduced
3
Closed
4
Top Buys
| 1 |
Insmed
INSM
|
$6.82M |
| 2 |
Denali Therapeutics
DNLI
|
$3.91M |
| 3 |
uniQure
QURE
|
$2.14M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$188K |
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$27.2M |
| 2 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$1.87M |
| 3 |
DERM
Dermira, Inc.
DERM
|
$1.58M |
| 4 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$1.11M |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$229K |
Sector Composition
| 1 | Healthcare | 22.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $117M | 40.96% | 3,100,146 -720,316 | -19% | -$27.2M |
|
|
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $99.9M | 34.92% | 1,672,714 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $19.6M | 6.83% | 1,558,108 +15,000 | +1% | +$188K |
|
|
4
Insmed
INSM
$28.8B
| $16.2M | 5.65% | 518,645 +218,645 | +73% | +$6.82M |
|
|
ALDR
5
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $12M | 4.18% | 1,043,832 | – | – |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $10.4M | 3.63% | 244,756 | – | – |
|
|
7
Denali Therapeutics
DNLI
$2.23B
| $3.91M | 1.37% | +250,000 | New | +$3.91M |
|
|
JUNO
8
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.89M | 1.36% | 85,000 -5,000 | -6% | -$229K |
|
|
9
uniQure
QURE
$896M
| $2.14M | 0.75% | +109,350 | New | +$2.14M |
|
|
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
| $1M | 0.35% | 11,900 -2,400 | -17% | -$202K |
|
11
Larimar Therapeutics
LRMR
$310M
| – | – | -30,775 | Closed | -$108K |
|
|
JNCE
12
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – | -119,912 | Closed | -$1.87M |
|
|
DERM
13
DELISTED
Dermira, Inc.
DERM
| – | – | -58,624 | Closed | -$1.58M |
|
|
OREX
14
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – | -523,132 | Closed | -$1.11M |
|